| abstract |
The subject of the present invention is a novel combination of active ingredients consisting of alfuzosin and a PDE4 inhibitor, and benign prostatic hypertrophy, urinary disorders, disorders associated with bladder dysfunction, lower with or without benign prostatic hypertrophy A pharmaceutical composition comprising them for ameliorating and / or treating urinary tract symptoms, urinary incontinence, subvesical urethral obstruction with or without benign prostatic hypertrophy, interstitial cystitis and overactive bladder . |